Paint strippers and prevention of occupational risks during building facelift: Where do we stand?

被引:0
|
作者
Hedouin-Langlet, C. [1 ]
Loizeau, M. [2 ]
Mercier, J. -L. [3 ]
Thiery, R. [4 ]
机构
[1] CRAMIF, Lab Toxicol Ind, Serv Prevent Risques Profess, F-75954 Paris 19, France
[2] APST BTP RP, F-92340 Bourg La Reine, France
[3] Agence IDF, OPPBTP, F-92660 Boulogne Billancourt, France
[4] Directe IDF, Pole Travail, F-93300 Aubervilliers, France
关键词
Stripper; Paint; Dichloromethane; Building facelift; Chemical risk;
D O I
10.1016/j.admp.2014.12.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. As part of the 2011-2014 regional health at work plan, a joint study was conducted by several agencies involved in occupational risk prevention, on substitutes for dichloromethane-based paint strippers, which are used for building facelift. Since June 6, 2012, construction professionals must substitute strippers containing more than 0.1% dichloromethane. Method. A field survey was conducted and stripper samples were analyzed from April to November 2013, in order to assess the chemical risk, check the composition of strippers, identify the most effective and the least dangerous ones and specify the conditions for their application. Results. Among the 31 commercial products taken, only one contained high concentrations of dichloromethane. The others still presented hazards as some of them were labeled "harmful, corrosive, irritating or flammable". Several substances classified as Carcinogenic, Mutagenic and Toxic to reproduction (CMR) according to regulatory requirements, including toluene, naphthalene, 1-ethyl-pyrrolidin-2-one were detected. The study highlights a major risk of facade fire related to the flammability of strippers. Among the stripper samples, only 50% had a flashpoint higher than 60 C (140 F). With the disappearance of dichloromethane, conditions of use have changed, requiring more time. Therefore, the whole organization of the works has to be reconsidered on the building site. Conclusion. The emergence of new dichloromethane-free strippers has given rise to other risks, such as the fire risk. The choice of the stripper must be made after having performed a risk assessment. Effective less hazardous strippers containing, for example, dibasic esters or dimethyl sulfoxide are available on the market: substitution is required. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
下载
收藏
页码:337 / 344
页数:8
相关论文
共 50 条
  • [1] Concrete release agents and prevention of occupational risks on the construction building sites: Where do we stand?
    Hedouin-Langlet, C.
    Loizeau, M.
    Brochet, F.
    Thiery, R.
    ARCHIVES DES MALADIES PROFESSIONNELLES ET DE L ENVIRONNEMENT, 2017, 78 (04) : 311 - 316
  • [2] Evidence of Health Risks from Occupational Sitting Where Do We Stand?
    Marshall, Simon
    Gyi, Diane
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2010, 39 (04) : 389 - 391
  • [3] Where do we stand in occupational cardiology?
    Karakulak, Ugur Nadir
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2015, 43 (06): : 581 - 581
  • [4] Occupational Rhinitis and Asthma: Where Do We Stand, Where Do We Go?
    Castano, Roberto
    Malo, Jean-Luc
    CURRENT ALLERGY AND ASTHMA REPORTS, 2010, 10 (02) : 135 - 142
  • [5] Occupational Rhinitis and Asthma: Where Do We Stand, Where Do We Go?
    Roberto Castano
    Jean-Luc Malo
    Current Allergy and Asthma Reports, 2010, 10 : 135 - 142
  • [6] ERGONOMICS AND OCCUPATIONAL 'STRESS' - WHERE DO WE STAND
    Baird, A. J.
    CONTEMPORARY ERGONOMICS AND HUMAN FACTORS 2010, 2010, : 350 - 359
  • [7] Prevention and treatment of stroke: Where do we stand?
    Gibaldi, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (09): : 784 - 790
  • [8] Colon Cancer Prevention 4.0 Where do we stand, where do we want to go?
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (04): : 375 - 376
  • [9] Probiotics for prevention of necrotizing enterocolitis: Where do we stand?
    Barbian, Maria Estefania
    Patel, Ravi Mangal
    SEMINARS IN PERINATOLOGY, 2023, 47 (01)
  • [10] Prevention initiative for dermatological malignancies: where do we stand?
    Stockfleth, E.
    Hinrichs, B.
    Surber, C.
    Christophers, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : V - VI